Form 8-K - Current report:
SEC Accession No. 0000950170-25-092350
Filing Date
2025-07-01
Accepted
2025-07-01 17:30:29
Documents
11
Period of Report
2025-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aktx-20250630.htm   iXBRL 8-K 97611
2 EX-10.1 aktx-ex10_1.htm EX-10.1 11782
  Complete submission text file 0000950170-25-092350.txt   331046

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aktx-20250630.xsd EX-101.SCH 97668
13 EXTRACTED XBRL INSTANCE DOCUMENT aktx-20250630_htm.xml XML 6056
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 251097556
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)